CNBX Pharmaceuticals Inc. (CNBX)
OTCMKTS: CNBX · Delayed Price · USD
0.0108
-0.0022 (-16.92%)
Apr 26, 2024, 3:42 PM EDT - Market closed
CNBX Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is September - August.
Millions USD. Fiscal year is Sep - Aug.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2005 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 0.13 | 0.12 | 1.39 | 0.78 | 0.27 | 1.39 | 3.37 | 0.02 | 0.03 | 0.1 | Upgrade
|
Short-Term Investments | 0 | 0 | 0 | 0 | 3.26 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Cash & Cash Equivalents | 0.13 | 0.12 | 1.39 | 0.78 | 3.52 | 1.39 | 3.37 | 0.02 | 0.03 | 0.1 | Upgrade
|
Cash Growth | 10.37% | -91.52% | 78.30% | -77.92% | 152.76% | -58.62% | 17507.02% | -24.19% | -74.46% | 35.75% | Upgrade
|
Receivables | 0.09 | 0.08 | 0.2 | 0.15 | 0.28 | 0.23 | 0.15 | 0 | 0 | 0 | Upgrade
|
Inventory | -0.09 | -0.08 | -0.2 | -0.15 | -3.26 | -0.23 | -0.15 | -0 | 0 | 0 | Upgrade
|
Other Current Assets | 0.09 | 0.08 | 0.2 | 0.15 | 3.76 | 0.23 | 0.15 | 0 | 0 | 0.01 | Upgrade
|
Total Current Assets | 0.22 | 0.2 | 1.59 | 0.93 | 4.31 | 1.62 | 3.52 | 0.02 | 0.03 | 0.11 | Upgrade
|
Property, Plant & Equipment | 0.27 | 0.44 | 0.64 | 0.86 | 1 | 0.97 | 0.12 | 0 | 0 | 0 | Upgrade
|
Long-Term Investments | 0 | 0.18 | 0.85 | 0.43 | 6.01 | 0.59 | 0 | 0 | 0 | 0 | Upgrade
|
Intangible Assets | 0 | 0 | 0 | 0 | 3.86 | 0 | 0 | 0 | 0 | 4.41 | Upgrade
|
Total Long-Term Assets | 0.27 | 0.61 | 1.49 | 1.29 | 10.88 | 1.56 | 0.12 | 0 | 0 | 4.41 | Upgrade
|
Total Assets | 0.5 | 0.81 | 3.08 | 2.22 | 15.18 | 3.18 | 3.64 | 0.02 | 0.03 | 4.52 | Upgrade
|
Accounts Payable | 0.34 | 0.46 | 0.18 | 0.23 | 0.22 | 0.32 | 0.39 | 0.27 | 0.11 | 0.03 | Upgrade
|
Deferred Revenue | -1.68 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Current Debt | 1.34 | 1.76 | 0.87 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Other Current Liabilities | 2.52 | 0.22 | 0.22 | 0.22 | 0.22 | 0.22 | 0.31 | 0.23 | 0.22 | 0.05 | Upgrade
|
Total Current Liabilities | 2.52 | 2.44 | 1.27 | 0.45 | 0.44 | 0.54 | 0.7 | 0.49 | 0.34 | 0.07 | Upgrade
|
Other Long-Term Liabilities | 0 | 0 | 0 | 0 | -0 | 0 | 1.4 | 0 | 0 | 0 | Upgrade
|
Total Long-Term Liabilities | 0 | 0 | 0 | 0 | -0 | 0 | 1.4 | 0 | 0 | 0 | Upgrade
|
Total Liabilities | 2.52 | 2.44 | 1.27 | 0.45 | 0.44 | 0.54 | 0.7 | 0.49 | 0.34 | 0.07 | Upgrade
|
Total Debt | 1.34 | 1.76 | 0.87 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Debt Growth | -23.60% | 101.71% | - | - | - | - | - | - | - | - | Upgrade
|
Common Stock | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
Retained Earnings | -24.26 | -20.55 | -16.83 | -13.63 | -6.16 | -7.3 | -3.52 | -1.59 | -1.28 | -0.74 | Upgrade
|
Comprehensive Income | 0 | -2.57 | -1.91 | -2.77 | 2.81 | -0.09 | -0.01 | -0 | -0 | -0 | Upgrade
|
Shareholders' Equity | -2.02 | -1.63 | 1.81 | 1.76 | 14.74 | 2.65 | 2.94 | -0.47 | -0.31 | 4.45 | Upgrade
|
Total Liabilities and Equity | 0.5 | 0.81 | 3.08 | 2.22 | 15.18 | 3.18 | 3.64 | 0.02 | 0.03 | 4.52 | Upgrade
|
Net Cash / Debt | -1.21 | -1.64 | 0.51 | 0.78 | 3.52 | 1.39 | 3.37 | 0.02 | 0.03 | 0.1 | Upgrade
|
Net Cash / Debt Growth | - | - | -33.83% | -77.92% | 152.76% | -58.62% | 17507.02% | -24.19% | -74.46% | - | Upgrade
|
Net Cash Per Share | -0.14 | -1.34 | 0.45 | 0.69 | 3.19 | 1.39 | 3.66 | 0.02 | 0.03 | 0.12 | Upgrade
|
Working Capital | -2.29 | -2.25 | 0.32 | 0.48 | 3.87 | 1.08 | 2.82 | -0.47 | -0.31 | 0.04 | Upgrade
|
Book Value Per Share | -0.23 | -1.34 | 1.56 | 1.57 | 13.36 | 2.64 | 3.19 | -0.54 | -0.37 | 5.33 | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.